X

Vous n'êtes pas connecté

Maroc Maroc - DRUGS.COM - Pharma Industry News - 03/Sep 20:12

SGLT-2 Inhibitors May Cut Dementia Risk in Patients With Diabetes

TUESDAY, Sept. 3, 2024 -- Sodium-glucose cotransporter-2 (SGLT-2) inhibitors may prevent dementia in middle-aged adults with diabetes, according to a study published online Aug. 28 in The BMJ.Anna Shin, from Seoul National University Bundang...

Articles similaires

Sorry! Image not available at this time

Research shows diabetes drug could reduce dementia risk. Here’s how diabetes and dementia may be linked

knowridge.com - 04/Sep 09:57

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower...

Sorry! Image not available at this time

Research shows diabetes drug could reduce dementia risk. Here’s how diabetes and dementia may be linked

knowridge.com - 04/Sep 09:57

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower...

Sorry! Image not available at this time

This common diabetes drug may cause dangerous infection, study finds

knowridge.com - 09/Sep 10:13

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a newer class of drugs used to manage diabetes, have recently been linked to a rare but serious...

Sorry! Image not available at this time

Diabetes, Prediabetes Tied to Accelerated Brain Aging

drugs.com - 10/Sep 15:09

TUESDAY, Sept. 10, 2024 -- Diabetes and prediabetes are associated with accelerated brain aging and potential dementia, according to a study published...

Sorry! Image not available at this time

Once-Weekly Efsitora Noninferior to Degludec for Type 2 Diabetes

drugs.com - 13/Sep 15:09

FRIDAY, Sept. 13, 2024 -- Once-weekly efsitora is noninferior to once-daily degludec for reducing glycated hemoglobin levels in adults with type 2...

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

news.medical.net - 13/Sep 11:39

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as...

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

news.medical.net - 13/Sep 11:39

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as...

Sorry! Image not available at this time

Dementia Diagnoses Up in Individuals With Acute Kidney Injury

drugs.com - 05/Sep 14:09

THURSDAY, Sept. 5, 2024 -- Individuals with acute kidney injury (AKI) have an increased risk for receiving a clinical diagnosis of dementia, according...

Sorry! Image not available at this time

Melanoma Incidence, Mortality Declining in Those Aged 30 to 49 Years

drugs.com - 10/Sep 16:09

TUESDAY, Sept. 10, 2024 -- For adults aged 30 to 49 years, there has been a decline in melanoma incidence and mortality, according to a study...

Sorry! Image not available at this time

Interleukin-6 May Boost Prediction of Obesity-Related Cancers

drugs.com - 03/Sep 16:09

TUESDAY, Sept. 3, 2024 -- In patients with newly diagnosed type 2 diabetes, baseline interleukin-6 (IL-6) levels may enhance prediction of new-onset...